Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
NCT00437450
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
99
Enrollment
OTHER
Sponsor class
Conditions
Anemia in Myelodysplastic Syndromes
Interventions
DRUG:
Epoetin/Atra
Sponsor
Groupe Francophone des Myelodysplasies